During the first quarter, the ClearBridge International Growth ACWI Ex-US Strategy outperformed its MSCI ACWI Ex-U.S. Index ...

Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Copenhagen, Denmark, March 27, 2025-Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based ...

Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based ...

Detailed price information for Zealand Pharma A/S (ZLDPF) from The Globe and Mail including charting and trades.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS – Research Report) and Zealand Pharma (ZLDPF ...

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Vicarious Surgical. The company’s shares closed last Monday at $9.63. According to TipRanks.com, Zimmerman is ...

Zealand Pharma (ZLDPF) announced that the last participant has been enrolled and randomized to active treatment or placebo in ZUPREME-1, a global Phase 2b trial in people with obesity or ...

Wall Street's major averages closed in the green on Friday, but the benchmark S&P 500 (SP500) posted a four-week losing streak for the first time since early August last year as President Donald ...